医学
内科学
2型糖尿病
队列
胰岛素抵抗
糖尿病
危险系数
优势比
胰岛素
内分泌学
置信区间
作者
Baoqi Fan,Hongjiang Wu,Mai Shi,Aimin Yang,Eric S. H. Lau,Claudia H.T. Tam,Dandan Mao,Cadmon K.P. Lim,Alice P.S. Kong,Ronald C.W.,Elaine Chow,Andrea O. Y. Luk,Juliana C.N. Chan
摘要
Abstract Aims Insulin deficiency (ID) and resistance (IR) contribute to progression from normal glucose tolerance to diabetes to insulin requirement although their relative contributions in young‐onset diabetes is unknown. Methods We examined the associations of HOMA2 using fasting plasma glucose and C‐peptide in Chinese aged 20–50 years with (1) progression to type 2 diabetes (T2D) in participants without diabetes in a community‐based cohort (1998–2013) and (2) glycaemic deterioration in patients with T2D in a clinic‐based cohort (1995–2014). We defined ID as HOMA2‐%B below median and insulin IR as HOMA2‐IR above median. Results During 10‐year follow‐up, 62 (17.9%) of 347 community‐dwelling participants progressed to T2D. After 8.6 years, 291 (48.1%) of 609 patients with T2D had glycaemic deterioration. At baseline, progressors for T2D had higher HOMA2‐IR, while in patients with T2D, progressors for glycaemic deterioration had higher HOMA2‐IR and lower HOMA2‐%B than non‐progressors. The non‐ID/IR group and the ID/IR group had an adjusted odds ratios of 2.47 (95% CI: 1.28, 4.94) and 5.36 (2.26, 12.79), respectively, for incident T2D versus the ID/non‐IR group. In patients with T2D, 50% of the ID/IR group required insulin at 6.7 years versus around 11 years in the non‐ID/IR or ID/non‐IR, and more than 15 years in the non‐ID/non‐IR group. Compared with the latter group, the adjusted hazard ratios were 2.74 (1.80, 4.16) in the ID/non‐IR, 2.73 (1.78, 4.19) in the non‐ID/IR and 4.46 (2.87, 6.91) in the ID/IR group ( p ‐interaction = 0.049). Conclusions In young Chinese adults, IR and ID contributed to progression to T2D and glycaemic deterioration.
科研通智能强力驱动
Strongly Powered by AbleSci AI